Cinctive Capital Management LP Buys New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

Cinctive Capital Management LP acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,189 shares of the healthcare conglomerate’s stock, valued at approximately $3,619,000.

Several other large investors also recently made changes to their positions in the company. Benjamin Edwards Inc. raised its position in shares of UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares during the period. Tealwood Asset Management Inc. bought a new position in shares of UnitedHealth Group in the third quarter valued at $2,905,000. Asset Planning Services Inc. LA ADV increased its position in shares of UnitedHealth Group by 1.2% during the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after acquiring an additional 150 shares in the last quarter. Captrust Financial Advisors lifted its position in UnitedHealth Group by 0.9% in the 3rd quarter. Captrust Financial Advisors now owns 210,464 shares of the healthcare conglomerate’s stock valued at $123,054,000 after acquiring an additional 1,789 shares in the last quarter. Finally, Sequoia Financial Advisors LLC increased its holdings in UnitedHealth Group by 13.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after purchasing an additional 3,006 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH opened at $608.48 on Tuesday. The company’s 50 day moving average is $585.43 and its 200-day moving average is $556.65. The firm has a market cap of $559.97 billion, a P/E ratio of 39.64, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period last year, the company earned $6.56 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.38%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. UBS Group cut their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Cantor Fitzgerald increased their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. Morgan Stanley cut their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. KeyCorp started coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $618.26.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.